DeepkinetiX

DeepkinetiX is thrilled to announce that we’ve joined the ?thos community—a global hub dedicated to fostering responsible AI ecosystems. Being part of ?thos not only gives us access to invaluable resources, networking opportunities, and industry insights, but also reinforces our commitment to advancing ethical, transformative innovations in healthcare. At DeepkinetiX, our mission is to transform preclinical drug development with ex vivo-guided, patient-specific digital twins, eliminating the need for unreliable animal models.?Joining ?thos accelerates our ability to drive this change, and we’re excited to collaborate with fellow innovators and thought leaders who share our passion for harnessing AI in responsible, impactful ways. #DeepkinetiX #?thos #ResponsibleAI #HealthcareInnovation #DigitalTwins #DrugDevelopment #EndAnimalTesting #PrecisionMedicin

Thank you to the Institute for Experiential AI at Northeastern University for an immersive day of AI, Healthcare, Sickcare, and Drug Discovery. Patricia Geli was honored to present the VC perspective of the landscape and share more about how collaboration across VC, industry, and academia is essential for co-creation of impactful AI ventures. It's also a good excuse to talk about our amazing portfolio companies like GuideAI Health, DeepkinetiX, and more! Thanks Samuel Scarpino and Eugene Tunik for organizing. It's always inspiring to hear from powerful voices in the field including Larry Brilliant, Usama Fayyad, Cansu Canca, Ph.D., John Brownstein, and many others! We look forward to the next one!

?? Demo Day at C10 Labs: Celebrating the Future of AI and Innovation As Venture Architect at C10 Labs, I had the absolute pleasure of seeing some of the brightest minds and most innovative startups present at our Demo Day on October 1st. With over 40 investors in the room, the energy was electric ?! The founders blew everyone away with their groundbreaking solutions, tackling big challenges across multiple industries. Congratulations to all the startups ??! Here are just some the stars that presented the other day: ?? HomeScore: The ultimate buyer sidekick! Like CarFax for homes, HomeScore takes the guesswork out of buying your dream home by providing detailed insights and guidance—helping you plan smarter, buy better. ?? Nurture Genomics: Revolutionizing pediatric care with proactive, ongoing childhood health screenings. Their platform helps families and pediatricians uncover hidden health risks, ensuring kids get the best possible outcomes early on. ?? ArtifexAI: Transforming urban planning with AI! ArtifexAI leverages local data and predictive algorithms to provide actionable insights for development projects, making communities smarter and more engaged. ??? CBase AI: Leading the way in AI-first data environments for the construction industry! CBase AI uses intelligent agents to automate and streamline data ops, taking the complexity out of managing massive construction projects. ?? Moneyball.ai: An investor’s best friend. MoneyBall is changing the game for early-stage private investors, using AI to streamline due diligence and help investors make better decisions faster—saving time and boosting returns. ? ?? PolicyMind: Shaping smarter public policies by leveraging AI to analyze global policy data. PolicyMind helps policymakers identify trends and create more effective policies that truly impact communities. ?? DeepkinetiX: Advancing precision medicine by using AI to create personalized therapeutic solutions. Their platform mimics the human immune microenvironment, providing biotech and pharma companies with cutting-edge tools for drug development. These startups are a testament to how AI is reshaping industries and unlocking new possibilities every day. A big congratulations ?? to all the founders who presented! ?? The future is bright, and I can’t wait to see where you all go from here!

DeepkinetiX (C2 Summer ‘24) is optimizing the drug development process by dramatically reducing R&D costs and time through Model-Informed Drug Development (MIDD) and AI-driven predictive insights. Founded by Dr. Ali Ghayoor, Dr. Hamed Gilzad Kohan, and Dr. Amir Aref, PhD, DeepkinetiX provides a cost-effective, faster, more precise, and ethically superior alternative to traditional animal-based methods. By leveraging #digitaltwin technology, DeepkinetiX accurately predicts effective dosages and potential clinical side effects of drug candidates during early development stages. This ensures streamlined processes and more reliable outcomes, accelerating the delivery of lifesaving therapies to patients in need. Key Products: - KinetixFlow: Streamlines PBPK, QSP, and PK/PD analysis, providing automated end-to-end reports with model-informed AI-generated predictive insights. - DeepDose Navigator: An AI companion designed for pharmacometricians and clinicians. Key Facts: - Drug development has about a 90% failure rate for clinical trial candidates. 40-45% of failures are due to poor prediction of a drug’s fate and behavior in the human body (inadequate biosimulation & PK/PD analysis). - By selecting better drug candidates earlier, DeepkinetiX reduces failure rates, cuts costs, and accelerates drug development. Learn more about how DeepkinetiX is reshaping drug development and making personalized, effective treatments a reality sooner: https://lnkd.in/e-yUDmuE #C10Labs #C2 #DeepkinetiX #AI #DrugDiscovery